Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
Designer Brands
DBI
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
RF Industries
RFIL
100%
0.0pp
Weis Markets
WMK
100%
0.0pp
Lantronix
LTRX
92%
-2.0pp
Segments
By segment
See full
Retail
24%
—
By geography
See full
China
60%
-22.1%
Other financials
Income statement
See full
Revenue
$696.4M
+1.4%
Gross profit
$315.3M
+7.1%
Operating income
$18.9M
+339%
Net income
$1.2M
+107%
EPS (diluted)
$0.02
+105%
Balance sheet
See full
Cash & equivalents
$50.1M
+8.9%
Total debt
$1.2B
-10.0%
Total equity
$280.9M
+6.6%
Total assets
$2.0B
-4.5%
Cash flow
See full
Operating cash flow
-$22.0M
-8.2%
CapEx
$9.9M
+36.5%
Free cash flow
-$31.9M
-15.6%
Valuation
See full
Market cap
$296.03M
+151%
Enterprise value
$1.47B
+2.6%
P/E
29×
—
P/S
0.1×
+0.1×
Profitability
See full
Gross margin
44.1%
+1.7pp
Operating margin
1.2%
+0.4pp
Net margin
0.4%
+0.2pp
FCF margin
2.5%
+1.2pp
Returns & leverage
See full
Return on equity
3.8%
+2.2pp
Debt / equity
4.4×
-0.8×
Current ratio
1.3×
0.0×